Literature DB >> 15292065

Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance.

Kristin M Seré1, Jan Rosing, Tilman M Hackeng.   

Abstract

The activated protein C (APC)-independent anticoagulant activity of protein S on tissue factor-induced thrombin generation was quantified in plasma. In absence of APC, protein S significantly decreased the endogenous thrombin potential (ETP) in a concentration-dependent manner. The APC-independent anticoagulant activity of protein S in plasma was not affected by phospholipid concentrations but strongly depended on tissue factor concentrations: protein S inhibited the ETP from 6% at 140 pM tissue factor to 74% at 1.4 pM tissue factor. Plasma with both 60% protein S and 140% prothrombin showed an ETP of 240% compared to normal plasma, suggesting an APC-independent protective role of protein S in the development of thrombosis as a result of protein S deficiency and the prothrombin-G20210A mutation. At high tissue-factor concentrations, protein S hardly expressed APC-independent anticoagulant activity but exerted potent APC-cofactor activity when thrombomodulin or APC were added to plasma. Neutralization of protein S under these conditions resulted in a 20-fold reduction of the anticoagulant activity of APC. The present study shows that protein S effectively regulates coagulation at 2 levels: at low procoagulant stimuli, protein S maintains the hemostatic balance by directly inhibiting thrombin formation, and at high procoagulant stimuli, protein S restores the hemostatic balance via its APC-cofactor activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292065     DOI: 10.1182/blood-2004-03-1146

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Endogenous thrombin potential changes during the first cycle of oral contraceptive use.

Authors:  Carolyn L Westhoff; Malcolm C Pike; Serge Cremers; Andrew Eisenberger; Stella Thomassen; Jan Rosing
Journal:  Contraception       Date:  2017-01-11       Impact factor: 3.375

2.  Analyses of protein S function.

Authors:  Kenneth G Mann
Journal:  Blood       Date:  2005-09-01       Impact factor: 22.113

3.  C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies.

Authors:  Alfonso Buil; David-Alexandre Trégouët; Juan Carlos Souto; Noémie Saut; Marine Germain; Maxime Rotival; Laurence Tiret; Françcois Cambien; Mark Lathrop; Tanja Zeller; Marie-Christine Alessi; Santiago Rodriguez de Cordoba; Thomas Münzel; Philipp Wild; Jordi Fontcuberta; France Gagnon; Joseph Emmerich; Laura Almasy; Stefan Blankenberg; José-Manuel Soria; Pierre-Emmanuel Morange
Journal:  Blood       Date:  2010-03-08       Impact factor: 22.113

4.  Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.

Authors:  Tilman M Hackeng; Kristin M Seré; Guido Tans; Jan Rosing
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-17       Impact factor: 11.205

5.  Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).

Authors:  Michael Dockal; Rudolf Hartmann; Markus Fries; M Christella L G D Thomassen; Alexandra Heinzmann; Hartmut Ehrlich; Jan Rosing; Frank Osterkamp; Thomas Polakowski; Ulrich Reineke; Andreas Griessner; Hans Brandstetter; Friedrich Scheiflinger
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

6.  Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain.

Authors:  Helena M Andersson; Márcia J Arantes; James T B Crawley; Brenda M Luken; Sinh Tran; Björn Dahlbäck; David A Lane; Suely M Rezende
Journal:  Blood       Date:  2010-03-22       Impact factor: 22.113

Review 7.  Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor.

Authors:  Susan A Maroney; Karen G Hansen; Alan E Mast
Journal:  Curr Opin Hematol       Date:  2013-09       Impact factor: 3.284

Review 8.  Tissue factor pathway inhibitor: structure-function.

Authors:  George J Broze; Thomas J Girard
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

9.  Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis.

Authors:  Michał Kukla; Marek Waluga; Michał Żorniak; Agnieszka Berdowska; Piotr Wosiewicz; Tomasz Sawczyn; Rafał J Bułdak; Marek Ochman; Katarzyna Ziora; Tadeusz Krzemiński; Marek Hartleb
Journal:  World J Gastroenterol       Date:  2017-04-14       Impact factor: 5.742

10.  High protein S activity due to C4b-binding protein deficiency in a 34-year-old Surinamese female with ischemic retinopathy.

Authors:  René Mulder; Jeroen K de Vries; Rogier P H M Müskens; André B Mulder; Michaël V Lukens
Journal:  Clin Case Rep       Date:  2018-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.